...
机译:根据替代治疗方式,当代转移性肾细胞癌患者生存的种族和民族差异
Univ Montreal Hlth Ctr Div Urol Hlth Outcomes Unit Canc Prognost Montreal QC Canada;
Univ Montreal Hlth Ctr Div Urol Hlth Outcomes Unit Canc Prognost Montreal QC Canada;
Univ Montreal Hlth Ctr Div Urol Hlth Outcomes Unit Canc Prognost Montreal QC Canada;
Univ Montreal Hlth Ctr Div Urol Hlth Outcomes Unit Canc Prognost Montreal QC Canada;
Univ Montreal Hlth Ctr Div Urol Hlth Outcomes Unit Canc Prognost Montreal QC Canada;
Univ Montreal Hlth Ctr Div Urol Hlth Outcomes Unit Canc Prognost Montreal QC Canada;
Univ Montreal Hlth Ctr Div Urol Hlth Outcomes Unit Canc Prognost Montreal QC Canada;
European Inst Oncology Dept Urol IRCCS Via Giuseppe Ripamonti 435 I-20141 Milan Italy;
Univ Milan Osped Maggiore Policlin IRCCS Fondaz Ca' Granda Dept Urol Milan Italy;
Med Univ Vienna Comprehens Canc Ctr Dept Urol Vienna Austria;
Univ Montreal Hlth Ctr Div Urol Hlth Outcomes Unit Canc Prognost Montreal QC Canada;
Urol Res Inst IRCCS San Raffaele Sci Inst Dept Urol Div Expt Oncology Milan Italy;
European Inst Oncology Dept Urol IRCCS Via Giuseppe Ripamonti 435 I-20141 Milan Italy;
Univ Montreal Hlth Ctr Div Urol Hlth Outcomes Unit Canc Prognost Montreal QC Canada;
African-American; Hispanic; Caucasian; Cytoreductive nephrectomy; Metastatic renal cell carcinoma; Systemic therapy;
机译:根据替代治疗方式,当代转移性肾细胞癌患者生存的种族和民族差异
机译:223?转移性肾细胞癌(MRCC)患者的结果差异,治疗免疫检查点抑制剂(ICI)治疗
机译:高加索肾细胞癌中孙尼尼患者的孙初差异评价:荟萃分析
机译:外科和全身治疗在局部晚期和转移性肾细胞癌中的整合
机译:用于诊断转移性肾细胞癌的患者的基于权利要求的基于权利要求的方法论方法
机译:大剂量白介素2治疗的当代经验及其对转移性黑色素瘤和转移性肾细胞癌患者生存的影响
机译:大剂量白介素2治疗的当代经验及其对转移性黑色素瘤和转移性肾细胞癌患者生存的影响